Abstract
The number of confirmed COVID -19 cases, relative to the population size, has varied greatly throughout the United States and, even, within the same city. In different zip codes in New York City, the epicentre of the epidemic, the number of cases per 100,000 residents has varied between 437 and 4227, i.e., in a 1:10 ratio. To guide policy decisions regarding containment and reopening of the economy, schools and other institutions, it is vital to identify which factors drive this large variation.
This paper reports on a statistical study of the incidence variation across New York City, conducted with data at zip code granularity. Among many socio-economical and demographic measures considered, the average household size emerges as the single most important explanatory variable: an increase of the average household size by one member accounts, in our final model specification, for at least 876 cases, a full 23% of the span of incidence numbers, at a 95% confidence level.
The percentage of the population above the age of 65, as well as that below the poverty line, are additional indicators with a significant impact on the case incidence rate, along with their interaction term.
Contrary to common belief, population density, per se, fails to have a significantly positive impact. Indeed, population densities and case incidence rates are negatively correlated, with a - 33% correlation coefficient.
Our model specification is anchored on a basic and established epidemiological model that explains the importance of household sizes on R0, the basic reproductive number of an epidemic.
Our findings support implemented and proposed policies to quarantine pre-acute and post-acute patients,, as well as nursing home admission policies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
None
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
Author Videos